Every SEC Form 3/4/5 on record for this filer (CIK 1201256) — 9 issuers, 21 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TVRD | Tvardi Therapeutics, Inc. | Director | 2025-04-17 → 2026-06-11 | 4 | — |
| MREO | Mereo BioPharma Group plc | Director | 2024-01-02 → 2026-02-27 | 5 | — |
| XFOR | X4 Pharmaceuticals, Inc | Director | 2019-03-14 → 2026-01-05 | 11 | $30,000 |
| IVVD | Invivyd, Inc. | Director · lapsed | 2023-05-25 → 2023-05-25 | 1 | — |
| LOGC | LogicBio Therapeutics, Inc. | Director · lapsed | 2018-10-18 → 2022-11-17 | 8 | — |
| ADGI | Adagio Therapeutics, Inc. | Director · lapsed | 2021-08-05 → 2022-06-24 | 3 | — |
| EXAS | EXACT SCIENCES CORP | Director · lapsed | 2015-07-27 → 2021-03-02 | 11 | −$4M |
| OMED | OncoMed Pharmaceuticals Inc | Director · lapsed | 2016-06-24 → 2018-06-25 | 3 | — |
| AKBA | Akebia Therapeutics, Inc. | Director · lapsed | 2016-06-20 → 2018-06-15 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| XFOR | 2023-08-18 | Buy | 25,000 | $1.20 | $30,000 | 76,667 |
| EXAS | 2021-02-26 | Sell | 19,021 | $130.11 | $2M | 2,558 |
5 of 9 issuers are covered and open a security page; the rest are on file here only.
